Anabolic-androgenic steroids can cause measurable enlargement of the clitoris in women, a change doctors call clitoromegaly. The effect stems from the high density of androgen receptors in clitoral tissue, which makes this particular structure highly responsive to testosterone and its synthetic relatives. How much growth occurs, how fast, and whether it reverses depends on the type of steroid, the dose, and the duration of exposure, and the story changes considerably depending on whether the steroids in question are prescribed therapeutically or used without medical supervision.
Why the Clitoris Responds So Strongly to Androgens
The clitoris and the penis develop from the same embryonic tissue, and both retain a dense population of androgen receptors into adulthood. Research using multiple detection methods has confirmed androgen receptors throughout the vulvovaginal region, including the labia majora, labia minora, clitoris, vestibule, and all three layers of the vaginal wall.1PubMed. Expression of androgen receptors in the structures of vulvovaginal tissue When circulating androgens rise, whether from an external source or from the body’s own production, the clitoris is one of the first structures to register the change. That shared embryonic origin is the reason the response looks so much like what testosterone does to penile tissue during male puberty: the organ grows, and its erectile tissue becomes more vascularized.
This sensitivity is not an accident or a pathology. It reflects basic developmental biology. The genital tubercle in the embryo differentiates into either a clitoris or a penis depending on hormonal signaling in utero. The receptor machinery that made that differentiation possible stays in place for life. So when a woman is exposed to androgens well above the normal female range, those dormant pathways get reactivated, and the tissue responds with growth that can be modest or dramatic depending on the dose.
Anabolic Steroid Use and Clitoral Enlargement
A systematic review and meta-analysis of studies on anabolic-androgenic steroid users found that clitoromegaly is among the documented reproductive effects in women, alongside menstrual irregularities and reduced fertility.2PubMed. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis Other sex-specific effects reported in female athletes using AAS include voice deepening, reduced breast volume, acne, and anxiety.3PubMed Central. Psychological traits associated with anabolic androgenic steroid use and dependence: an exploratory cross-sectional study among female athletes
The clitoral changes tend to appear relatively early compared to other virilizing effects. Voice changes, for instance, usually take weeks to months of sustained use. Clitoral growth can begin within the first cycle of steroid use, partly because of that dense receptor population and partly because the clitoris is a small structure where even modest tissue expansion is noticeable. Women who use multiple compounds or higher doses typically see more pronounced changes, but individual variation is wide. Some women report noticeable growth on doses that produce no visible effect in others.
Reversibility Is Partial at Best
This is the question most women want answered, and the honest answer is frustrating: clitoral enlargement from anabolic steroids is considered one of the least reversible virilizing effects. Acne clears up after cessation. Menstrual cycles usually return within a few months. Body hair growth may slow but often persists. Voice changes are notoriously persistent because testosterone thickens the vocal cords and that structural change does not undo itself. Clitoral growth falls into a similar category. Once the erectile tissue has expanded and the surrounding connective tissue has remodeled, stopping the steroid does not shrink the organ back to its original size. Some degree of regression can occur, particularly if the exposure was brief, but complete reversal is uncommon in clinical reports.
The mechanism behind this persistence is structural remodeling. Androgens do not just cause temporary swelling. They stimulate actual tissue growth, new smooth muscle, additional vascular channels, and connective tissue expansion. Reversing that would require the body to actively break down and reabsorb functional tissue, which it does not do efficiently in this location. Women who used steroids briefly at lower doses are more likely to see meaningful regression than those with prolonged high-dose exposure, but “meaningful” is relative. The change may become less conspicuous without disappearing entirely.
Therapeutic Testosterone Is a Different Scenario
Not all testosterone exposure carries the same risk. Physicians sometimes prescribe low-dose testosterone for women, most commonly for sexual dysfunction. A study examining the effects of therapeutic testosterone on clitoral blood flow in women with sexual dysfunction found improved clitoral hemodynamics without producing clitoromegaly. The researchers specifically noted that the absence of clitoral enlargement at therapeutic doses was clinically relevant, since clitoromegaly can serve as a marker of systemic testosterone overtreatment.4PubMed Central. Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction
The difference is dose-dependent. Therapeutic testosterone for women aims to bring levels into the upper end of the normal female range or slightly above it. Anabolic steroid doses used for physique or performance enhancement routinely push testosterone levels into the male range or far beyond it. That gap, often a factor of ten or more, explains why one produces clinical benefit without visible anatomical change while the other remodels genital tissue. A woman taking a medically supervised testosterone patch or cream at a standard dose is in a fundamentally different pharmacological situation than a woman injecting trenbolone or taking oral stanozolol.
That said, therapeutic testosterone is not risk-free. Other androgenic effects such as acne, hirsutism, voice changes, and hair thinning can occur even at prescribed doses, particularly in women who are more sensitive to androgens or who use testosterone for extended periods.5PubMed Central. Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction Monitoring blood levels is the main safeguard against crossing the line from therapeutic benefit to unwanted virilization.
Topical Testosterone Can Act Faster Than You Might Expect
One commonly underappreciated scenario involves topical testosterone applied directly to the vulvar area. Testosterone creams are sometimes used to treat lichen sclerosus, a chronic skin condition that causes thinning and scarring of vulvar tissue. A study of women treated with topical testosterone for lichen sclerosus found that four out of ten patients developed clinical signs of excess androgen exposure, including clitoral enlargement, voice changes, and increased libido, after just four weeks of treatment.6Obstetrics & Gynecology. Short-term effects of topical testosterone in vulvar lichen sclerosus
Four weeks is a remarkably short window for visible structural changes, and it highlights how directly the genital tissues absorb androgens when the hormone is applied locally. The concentration at the tissue level can be very high even if the total systemic dose is small. This finding contributed to a shift in clinical practice: topical testosterone for lichen sclerosus has largely been replaced by other treatments, in part because the risk of local virilization turned out to be higher than anticipated.
Corticosteroids Are a Completely Different Drug Class
A common source of confusion is the word “steroid” itself. Corticosteroids, the anti-inflammatory drugs prescribed for skin conditions, asthma, and autoimmune disorders, are biochemically unrelated to anabolic-androgenic steroids in terms of their receptor targets. Applying a corticosteroid cream to the vulvar area does not cause clitoral enlargement. It can, however, cause a different set of problems. Long-term use of topical glucocorticoids on vulvar skin has been associated with skin atrophy, where the tissue becomes thin, fragile, and prone to tearing.7PubMed Central. Vulvar Skin Atrophy Induced by Topical Glucocorticoids
So if you have been prescribed a corticosteroid ointment for a vulvar condition like lichen sclerosus or eczema, clitoral growth is not a concern. Skin thinning is. The two drug classes share a name fragment and nothing else in terms of how they affect genital tissue. If your doctor prescribes “a steroid cream,” clarifying whether it is a corticosteroid or an androgen matters, because the risks are opposite in kind.
The Emotional and Psychological Dimension
Clitoral enlargement does not exist in a vacuum. For many women, it carries a significant psychological burden. Qualitative research with women who used anabolic-androgenic steroids found that clitoral enlargement gave rise to shame and reduced self-esteem. However, the emotional impact was not uniform: women reported that negative feelings could be reduced by a positive partner response. Increased libido was another common effect, and whether it was experienced positively or negatively depended on life situation, partner status, and whether genital changes had also occurred.8PubMed. Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects
The interplay between increased libido and body shame is especially complicated. Some women described feeling more sexually responsive than ever before but simultaneously reluctant to be physically intimate because of how their genitals looked or felt. Others found the combination empowering, particularly when their partner reacted without alarm. The individual variation in emotional response is enormous, and it tracks poorly with the degree of physical change. A woman with relatively modest clitoral growth might experience more distress than someone with a more pronounced change, depending entirely on her psychological relationship with her body and the reactions of people around her.
When the Body Produces Too Much Androgen on Its Own
Steroid exposure does not always come from a pill or injection. Some medical conditions cause the body to produce very high levels of androgens naturally, and the clitoral effects are the same. One such condition is hyperreactio luteinalis, a rare pregnancy complication in which the ovaries become massively enlarged and testosterone production skyrockets. A study of this condition found that in clinically symptomatic women (those who actually showed virilization), testosterone levels ranged from roughly 14 to 198 nmol/L, while some women with similarly high testosterone, up to 37 nmol/L, showed no virilizing signs at all.9PubMed Central. Testosterone serum levels are not predictive of maternal virilization in hyperreactio luteinalis
That overlap is striking. Some women tolerate testosterone concentrations in the male range without developing visible virilization, while others virilize at much lower levels. The implication is that clitoral sensitivity to androgens varies substantially between individuals, likely because of differences in receptor density, receptor sensitivity, and the activity of enzymes that convert testosterone to its more potent form. This individual variability helps explain why two women taking the same steroid at the same dose can have very different outcomes.
Gender-Affirming Testosterone Therapy
For transgender men and some nonbinary people, clitoral growth from testosterone is not a side effect but an expected and often desired outcome. Testosterone therapy in this context is prescribed at doses intended to bring levels into the typical male range, and clitoral enlargement is one of the earliest physical changes, usually noticeable within the first few months of treatment. A study of individuals who underwent metoidioplasty, a surgical procedure that uses testosterone-enlarged clitoral tissue to create a neophallus, found that the median stretched clitoral length before surgery was about 5.8 cm after a period of testosterone use.10PubMed Central. Assessment of neophallus length following metoidioplasty That figure represents a substantial increase from the typical unstimulated clitoral length, which averages around 1.5 to 2 cm including the visible glans and the underlying body.
Interestingly, the same study found that time spent on testosterone had only a weak and statistically insignificant correlation with stretched clitoral length.11PubMed Central. Assessment of neophallus length following metoidioplasty In other words, most of the growth appears to happen in the first year or two, and additional years of testosterone do not produce proportionally more growth. This plateau effect suggests that the androgen receptors in clitoral tissue become maximally stimulated relatively early in the course of hormone therapy, after which further growth is limited by the tissue’s structural capacity rather than by hormonal exposure.
Lessons from Veterinary Science
Some of the earliest controlled evidence that androgens reshape clitoral tissue came not from human medicine but from veterinary research. Studies examining female veal calves that had been implanted with anabolic steroids found specific histological changes in the clitoris, described as a preputial-like separation of the clitoral epithelium, which was attributed to androgenic activity. This tissue change was distinct enough to be used as a screening tool for detecting illegal anabolic steroid use in livestock.12PubMed. Histological changes in the genital tract of female veal calves implanted with naturally occurring anabolic steroids
The spotted hyena offers an even more dramatic example. Female spotted hyenas mate and give birth through a peniform clitoris that is essentially indistinguishable from the male’s penis in external appearance. This extraordinary anatomy is shaped by exposure to naturally circulating maternal androgens during fetal development.13PubMed Central. Exposure to naturally circulating androgens during foetal life incurs direct reproductive costs in female spotted hyenas, but is prerequisite for male mating The hyena case is extreme, but it illustrates the same basic principle at work in human clitoral enlargement: androgen receptors in this tissue are responsive across mammalian species, and the degree of growth scales with the level and timing of androgen exposure. In humans, the mechanism is the same; only the scale is different.
What to Tell Your Doctor
If you are experiencing clitoral enlargement and you are not on gender-affirming hormone therapy, it warrants a medical conversation. For women using anabolic steroids recreationally, the most effective harm reduction step is stopping the compound as early as possible once virilizing changes begin. The earlier the cessation, the greater the chance of at least partial regression. Continuing use after noticeable clitoral growth is a decision to accept a change that may be permanent.
For women on prescribed testosterone, the appearance of clitoral enlargement is a clinical signal that the dose may be too high or that individual sensitivity is greater than expected. As the hemodynamics study noted, clitoromegaly at therapeutic doses serves as a red flag for overtreatment.14PubMed Central. Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction Dose adjustment or discontinuation is typically the next step, and the decision should involve honest reporting of symptoms. Some women hesitate to mention genital changes to their providers, but this is exactly the kind of information that guides safe prescribing.
For women who discover clitoral enlargement without any known steroid exposure, an endocrine workup is appropriate. Conditions like polycystic ovary syndrome, adrenal tumors, and ovarian tumors can all elevate androgen levels enough to produce virilization. Clitoral growth in the absence of exogenous steroids is not normal and should not be dismissed as anatomical variation without at least checking hormone levels.